{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:23Z","timestamp":1791478343825,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-07773-4","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:24:53Z","timestamp":1783769093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility & clinical utility of Comprehensive Geriatric Assessment (CGA) and interventions in older adults with prostate cancer on Androgen Deprivation Therapy (ADT); a retrospective service evaluation"],"prefix":"10.1186","volume":"26","author":[{"given":"K","family":"Balachandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lightbody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Fleure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Enting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kalsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"7773_CR1","unstructured":"; CRUK, Available. from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer#heading-Zero"},{"issue":"3","key":"7773_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"7773_CR3","unstructured":"Prostate Cancer UK. Available from: https:\/\/prostatecanceruk.org\/prostate-information\/about-prostate-cancer"},{"issue":"5","key":"7773_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","volume":"67","author":"PL Nguyen","year":"2015","unstructured":"Nguyen PL, et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. 2015;67(5):825\u201336.","journal-title":"Eur Urol"},{"issue":"2 Suppl 1","key":"7773_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","volume":"61","author":"CS Higano","year":"2003","unstructured":"Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology. 2003;61(2 Suppl 1):32\u20138.","journal-title":"Urology"},{"issue":"10","key":"7773_CR6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1201546","volume":"367","author":"JM Crook","year":"2012","unstructured":"Crook JM, et al. Intermittent androgen suppression for rising PSA level after radiotherapy. N Engl J Med. 2012;367(10):895\u2013903.","journal-title":"N Engl J Med"},{"key":"7773_CR7","unstructured":"SEER. 2023. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html"},{"key":"7773_CR8","unstructured":"United Nations. World Population Ageing 2019; Available from: https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WorldPopulationAgeing2019-Highlights.pdfaccessed"},{"key":"7773_CR9","unstructured":"National Prostate Cancer Audit. National Prostate Cancer Audit Report: Patient and tumour characteristics associated with metastatic prostate cancer diagnoses in England. 2022."},{"issue":"8878","key":"7773_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/0140-6736(93)92884-V","volume":"342","author":"AE Stuck","year":"1993","unstructured":"Stuck AE, et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993;342(8878):1032\u20136.","journal-title":"Lancet"},{"key":"7773_CR11","doi-asserted-by":"crossref","unstructured":"Ellis G et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2011(7): p. Cd006211.","DOI":"10.1002\/14651858.CD006211.pub2"},{"issue":"2","key":"7773_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/ageing\/afl163","volume":"36","author":"D Harari","year":"2007","unstructured":"Harari D, et al. Proactive care of older people undergoing surgery (\u2018POPS\u2019): designing, embedding, evaluating and funding a comprehensive geriatric assessment service for older elective surgical patients. Age Ageing. 2007;36(2):190\u20136.","journal-title":"Age Ageing"},{"issue":"1017","key":"7773_CR13","first-page":"72","volume":"109","author":"JR Elliot","year":"1996","unstructured":"Elliot JR, et al. The added effectiveness of early geriatrician involvement on acute orthopaedic wards to orthogeriatric rehabilitation. N Z Med J. 1996;109(1017):72\u20133.","journal-title":"N Z Med J"},{"issue":"9","key":"7773_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/bjc.2015.120","volume":"112","author":"T Kalsi","year":"2015","unstructured":"Kalsi T, et al. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer. 2015;112(9):1435\u201344.","journal-title":"Br J Cancer"},{"issue":"9","key":"7773_CR15","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/S2666-7568(22)00169-6","volume":"3","author":"WK Soo","year":"2022","unstructured":"Soo WK, et al. Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial. Lancet Healthy Longev. 2022;3(9):e617\u201327.","journal-title":"Lancet Healthy Longev"},{"issue":"10314","key":"7773_CR16","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894\u2013904.","journal-title":"Lancet"},{"issue":"11","key":"7773_CR17","doi-asserted-by":"publisher","first-page":"e214158","DOI":"10.1001\/jamaoncol.2021.4158","volume":"7","author":"D Li","year":"2021","unstructured":"Li D, et al. Geriatric Assessment\u2013Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial. JAMA Oncol. 2021;7(11):e214158\u2013214158.","journal-title":"JAMA Oncol"},{"issue":"12","key":"7773_CR18","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/s41416-021-01367-0","volume":"124","author":"CM Lund","year":"2021","unstructured":"Lund CM, et al. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). Br J Cancer. 2021;124(12):1949\u201358.","journal-title":"Br J Cancer"},{"issue":"8","key":"7773_CR19","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","volume":"23","author":"CA Bellera","year":"2012","unstructured":"Bellera CA, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166\u201372.","journal-title":"Ann Oncol"},{"issue":"6","key":"7773_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/j.1532-5415.2006.00738.x","volume":"54","author":"K Rockwood","year":"2006","unstructured":"Rockwood K, et al. Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc. 2006;54(6):975\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"7773_CR21","unstructured":"Cree A et al. Implementing frailty assessment and management in oncology services. 2023."},{"issue":"27","key":"7773_CR22","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating NL, O\u2019Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006;24(27):4448\u201356.","journal-title":"J Clin Oncol"},{"issue":"17","key":"7773_CR23","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","volume":"25","author":"AV D\u2019Amico","year":"2007","unstructured":"D\u2019Amico AV, et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol. 2007;25(17):2420\u20135.","journal-title":"J Clin Oncol"},{"key":"7773_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.urology.2016.06.024","volume":"96","author":"G Morgia","year":"2016","unstructured":"Morgia G, et al. Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study. Urology. 2016;96:165\u201370.","journal-title":"Urology"},{"key":"7773_CR25","first-page":"87","volume":"14","author":"E Choi","year":"2022","unstructured":"Choi E, et al. Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers. Res Rep Urol. 2022;14:87\u2013108.","journal-title":"Res Rep Urol"},{"issue":"6","key":"7773_CR26","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1210\/jc.2007-2595","volume":"93","author":"S Shahani","year":"2008","unstructured":"Shahani S, Braga-Basaria M, Basaria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab. 2008;93(6):2042\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7773_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jjco\/hyv025","volume":"45","author":"JY Teoh","year":"2015","unstructured":"Teoh JY, et al. Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong. Jpn J Clin Oncol. 2015;45(5):483\u20137.","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"7773_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","volume":"121","author":"GN Levine","year":"2010","unstructured":"Levine GN, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation. 2010;121(6):833\u201340.","journal-title":"Circulation"},{"issue":"5","key":"7773_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIRCULATIONAHA.115.012519","volume":"133","author":"N Bhatia","year":"2016","unstructured":"Bhatia N, et al. Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer. Circulation. 2016;133(5):537\u201341.","journal-title":"Circulation"},{"issue":"10","key":"7773_CR30","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/cncr.21047","volume":"103","author":"MM Agarwal","year":"2005","unstructured":"Agarwal MM, et al. Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy. Cancer. 2005;103(10):2042\u201352.","journal-title":"Cancer"},{"issue":"5","key":"7773_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.amepre.2004.02.013","volume":"26","author":"LN Bakhireva","year":"2004","unstructured":"Bakhireva LN, et al. Modifiable predictors of bone loss in older men: a prospective study. Am J Prev Med. 2004;26(5):436\u201342.","journal-title":"Am J Prev Med"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07773-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07773-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07773-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:33Z","timestamp":1791475413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07773-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7773"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07773-4","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was deemed unnecessary for this project according to national regulations (please see supporting Health Research Authority documentation). Therefore, this study was not submitted to a local ethics committee or institutional review board. No experiments on humans and\/or human tissue samples were performed or reported in this study. The need for consent to participate was deemed unnecessary according to national regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1263"}}